Crossmark

Retrospective, multi-centre, open-label study on the use of alemtuzumab for relapsing–remitting multiple sclerosis in clinical practice: A 4-year follow-up

Crossref DOI link: https://doi.org/10.1016/j.neurop.2025.100192

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pato-Pato, A.

Gabeiras-Araujo, P.

Lorenzo-García, M.

Hernandez-Cerón, C.

Lorenzo-González, J.R.

García-Estévez, D.A.
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-04-02
More Information

This article is maintained by: Elsevier

Article Title: Retrospective, multi-centre, open-label study on the use of alemtuzumab for relapsing–remitting multiple sclerosis in clinical practice: A 4-year follow-up

Journal Title: Neurology Perspectives

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.neurop.2025.100192

Content Type: article

Copyright: © 2025 Sociedad Española de Neurología. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below